Companies

Avalo Therapeutics, Inc. (AVTX) SEC filings

CIK 0001534120 · Pharmaceutical Preparations (SIC 2834) · Nasdaq · incorporated in DE · fiscal year ends 12/31

Annual financials (from the company's own XBRL in its 10-K filings)

FY2025FY2024FY2023FY2022
Revenue (USD)590001.9 M18.1 M
Net income (USD)-41.7 M-84.4 M
Diluted EPS (USD/shares)-5.84-113.58-1063

Latest filings

FiledFormDescriptionPeriod
2026-10-02442026-09-30
2026-10-02442026-09-30
2026-10-02442026-09-30
2026-09-18442026-09-16
2026-09-11442026-09-10
2026-09-01442026-08-28
2026-08-19442026-08-17
2026-08-19442026-08-17
2026-08-18144144
2026-08-17144144
2026-08-17144144
2026-08-17144144
2026-08-14SCHEDULE 13G/ASCHEDULE 13G/A
2026-08-14SCHEDULE 13G/ASCHEDULE 13G/A
2026-08-14SCHEDULE 13G/ASCHEDULE 13G/A
2026-08-14SCHEDULE 13G/ASCHEDULE 13G/A
2026-08-14SCHEDULE 13G/ASCHEDULE 13G/A
2026-08-14SCHEDULE 13G/ASCHEDULE 13G/A
2026-08-14SCHEDULE 13G/ASCHEDULE 13G/A
2026-08-13SCHEDULE 13G/ASCHEDULE 13G/A
2026-08-12442026-08-11
2026-08-12442026-08-10
2026-08-11144144
2026-08-10144144
2026-08-07SCHEDULE 13G/ASCHEDULE 13G/A

Forms on file (last 1,000): 4 428, 8-K 174, SCHEDULE 13G/A 39, 3 38, 10-Q 29, SC 13D/A 29, 424B3 28, SCHEDULE 13G 22. Source: SEC EDGAR, as filed; this page is public data and not investment advice.

For software and AI agents: the same data as JSON, per call, no account: GET https://store.agentexchange.work/gw/filings/company?ticker=AVTX (0.002 USD), /gw/filings/filings?ticker=AVTX&form=8-K, /gw/filings/facts?ticker=AVTX&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txt

Updated from EDGAR within 30 minutes of a filing. Agent Exchange